Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial-Reference-Cited by-同舟云学术

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Published:2016-02 Issue:10021 Volume:387 Page:857-865
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ganz Patricia A,Cecchini Reena S,Julian Thomas B,Margolese Richard G,Costantino Joseph P,Vallow Laura A,Albain Kathy S,Whitworth Patrick W,Cianfrocca Mary E,Brufsky Adam M,Gross Howard M,Soori Gamini S,Hopkins Judith O,Fehrenbacher Louis,Sturtz Keren,Wozniak Timothy F,Seay Thomas E,Mamounas Eleftherios P,Wolmark Norman

Funder

AstraZeneca Pharmaceuticals and the National Cancer Institute

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Breast Cancer Facts and Figures 2015–2016,2015

2. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer;Fisher;N Engl J Med,1993

3. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17;Fisher;J Clin Oncol,1998

4. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience;Fisher;Semin Oncol,2001

5. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial;Fisher;Lancet,1999

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing menopause after cancer;The Lancet;2024-03

2. Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial;Cancer Prevention Research;2023-09-26

3. Shoulder function and health outcomes in newly diagnosed breast cancer patients receiving surgery: a prospective study;Clinical Breast Cancer;2023-06

4. Non-systemic Approaches for Ductal Carcinoma In Situ: Exploring the Potential of Ultra-flexible Combisomes as a Novel Drug Delivery Strategy—a Review;AAPS PharmSciTech;2023-05-12

5. Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study;eLife;2023-02-06